Ризедронат Тева 35 мг
Country: Israel
Language: Russian
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RISEDRONIC ACID AS SODIUM 35 MG
Available from:
ABIC MARKETING LTD
ATC code:
M05BA07
Pharmaceutical form:
TABLETS
Administration route:
PER OS
Manufactured by:
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
Therapeutic group:
RISEDRONIC ACID
Therapeutic indications:
Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.
Authorization date:
2011-10-01
